utilized the 68Ga-PSMA-11 PET Maximum Normalized Threshold (SUVmax) to predict clinically significant prostate cancer (PCa) and PSA levels in the gray area (4-10 ng/ml), which is challenging for PCa diagnosis. The gene discussed is FOLH1; the disease is prostate carcinoma.